oath media heat uptake mani drug eg station transportermedi drugdruginteract doi bortezomib firstinclass proteasome inhibitor drug approve u food administer treatment multiple myeloma potent caps oatpmedi ass current studi investing involve ubiquitinproteasom system up degrade determine effect inhibitor oatpbmedi transport coimmunoprecipit flagoatpbb ubiquitin observe human embryo kidney he cell cotransfect flagtag oatpboatpb hemagglutinin data ubiquitin suggest ubiquitinmodifi although block active nm h increase endowed ubiquitinconjug flagoatpb hekflagoatpb andoatpb affect total protein level play minor role constitute conduit retreat significantly decrease hack specify substrate hekoatpb sandwichcultur hepatocyt sch howe degli heÎ²g hpitavastatin dual substrate hekoatpbb ndor compare vehicle control maxim below max cc v pmolmg proteinmin without affect affine constant km value mg epoxomicin carfilzomib also summary studi first time report ubiquitin appear substratedepend inhibitor effect data suggest low risk caps 